Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129250) titled 'A Real-World Study on the Efficacy and Safety of Isavuconazole in the Treatment of Invasive Mold Disease in Children' on Aug. 1.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Childrens Hospital,Capital Medical University
Condition:
Invasive Mold Disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Isavuconazole group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335825
Published by HT Digital Content Services with permission from Health Daily Digest....